• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>ID Cases >Percutaneous coronary intervention-associated Actinomyces oris
【24h】

Percutaneous coronary intervention-associated Actinomyces oris

机译：经皮冠状动脉干预相关放放液oris

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Coronary artery interventions are safe procedures yet have a risk of stent infection, bacteremia and sepsis, events that are rare but with high morbidity and mortality sequel. A few prior cases had reported post percutaneous coronary intervention (PCI) infections, abscesses and sepsis due toStaphylococcus aureus, followed byPseudomonas aeruginosa.Cardiac Actinomyces infections are extremely rare. Here we report a case of a 50?year old patient who developed a post interventionActinomyces orisepicardial abscess occluding right coronary artery with subsequent bacteremia eventually requiring open heart surgery. He was treated during and thereafter with IV penicillin and ceftriaxone for almost 8 weeks. We highlight during this review the available literature regarding risk factors, the possible theories of acquiring such bacterium at this unusual site as well as our patient’s course and treatment outcome.
机译：冠状动脉干预是安全的手术，但患有支架感染，菌血症和败血症的风险，罕见的事件，但具有高发病率和死亡序列。几例之前的病例报告过经皮冠状动脉干预（PCI）感染，脓肿和脓毒症患者曲氏葡萄球菌，其次是Bypseudomonas Aeruginosa.cardiac actinyces感染极少数。在这里，我们举报了一个50？岁的患者，他们开发了一种术后介入的术后脓肿脓肿，随后的菌丝最终需要开放心脏手术，可闭合冠状动脉。他在此后接受治疗，静脉曲霉素和头孢曲松近8周。我们突出显示了在此评论中，有关风险因素的可用文献，在这种不寻常的网站和患者的课程和治疗结果中获取此类细菌的可能理论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号